Acambis Financial Statements
Acambis Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Acambis Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 19.0 | 60.5 | 85.7 |
| Gross Profit ($ mil.) | -- | -- | 38.2 |
| Operating Income ($ mil.) | -- | -- | (37.5) |
| Total Net Income ($ mil.) | -- | -- | (34.9) |
| Diluted EPS (Net Income) | -- | -- | (55.97) |
Acambis Stock Quote & Chart
•
•
--
•
•
%
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Acambis Competitive Intelligence
| Merck | Sanofi Pasteur | Wyeth Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 24,197.7 | 3,341.8 | 16,884.2 |
| Employees | 59,800 | 9,808 | 4,500 |
| Market Cap ($ mil.) | 77,471.9 | -- | -- |
